NEW YORK (GenomeWeb) – VolitionRx today announced it has closed its public offering of 2,475,000 shares of stock at an offering price of $3.75 per share for net proceeds of about $8.5 million.

The firm's stock began trading on the New York Stock Exchange MKT on Feb. 6, under the ticker symbol "VNRX."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.